STAT Plus: Pharmacy head who researched Zantac link to carcinogen says FDA has ‘downplayed the problem’
ADOBE
"We think it’s very important to understand this is an inherent problem with the drug," says David Light, CEO and co-founder of Valisure.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario